What is the active ingredient in Vascepa (icosapent ethyl)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vascepa Ingredients

The active ingredient in Vascepa is icosapent ethyl, a highly purified ethyl ester of eicosapentaenoic acid (EPA), containing ≥96% EPA ethyl ester without docosahexaenoic acid (DHA). 1

Active Ingredient

  • Icosapent ethyl is the sole active pharmaceutical ingredient, which is an ethyl ester of the omega-3 fatty acid eicosapentaenoic acid (EPA) 1
  • The empirical formula is C₂₂H₃₄O₂ with a molecular weight of 330.51 1
  • The chemical name is ethyl all-cis-5,8,11,14,17-icosapentaenoate 1
  • Each capsule contains 1 gram of icosapent ethyl 1
  • The formulation contains ≥96% of the EPA ethyl ester and does not contain DHA, distinguishing it from other omega-3 products 2, 3

Inactive Ingredients (Excipients)

The capsule shell and formulation contain the following inactive ingredients 1:

  • Alpha tocopherol (vitamin E, used as an antioxidant)
  • Gelatin (capsule shell material)
  • Glycerin (capsule plasticizer)
  • Mannitol (sweetener/bulking agent)
  • Sorbitol (sweetener/humectant)
  • Purified water

Capsule Imprinting Ingredients

The white imprinting ink (Opacode NSP-78-18022 White) contains 1:

  • Ammonium hydroxide
  • Macrogol (polyethylene glycol)
  • Polyvinyl acetate phthalate
  • Propylene glycol
  • Titanium dioxide

Key Distinguishing Features

  • EPA-only formulation: Unlike combination omega-3 products (such as Lovaza or Epanova) that contain both EPA and DHA, Vascepa contains only EPA 2, 4
  • High purity: The ≥96% purity level distinguishes it from over-the-counter fish oil supplements and other prescription omega-3 products 2, 3
  • No DHA content: This is clinically significant because DHA has been associated with increased LDL-C levels, while icosapent ethyl does not raise LDL-C 2, 3, 4

Clinical Formulation Details

  • Available as 0.5 gram and 1 gram capsules 1
  • The capsules are transparent, natural-colored, oblong-shaped, liquid-filled soft gelatin capsules 1
  • Icosapent ethyl is de-esterified to EPA following oral administration 2
  • Maximum daily dose is 4 grams (either 8 capsules of 0.5g or 4 capsules of 1g) 1

References

Research

Icosapent ethyl: a review of its use in severe hypertriglyceridemia.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2014

Research

Icosapent ethyl for the treatment of hypertriglyceridemia.

Expert opinion on pharmacotherapy, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.